NVGN - Novogen Limited

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue3,0312,184405
Cost of Revenue---
Gross Profit3,0312,184405
Operating Expenses
Research Development7,3674,5623,141
Selling General and Administrative4,2902,9543,223
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-8,625-5,331-5,959
Income from Continuing Operations
Total Other Income/Expenses Net-425-231-510
Earnings Before Interest and Taxes-9,051-5,562-6,469
Interest Expense-53675
Income Before Tax-9,051-5,615-7,144
Income Tax Expense---
Minority Interest--233-92
Net Income From Continuing Ops-9,051-5,615-7,144
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-9,051-5,615-7,144
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-9,051-5,615-7,144